- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT04700306
Evaluation of the Added Value of Sophrology on the Intensity of Craving During Smoking Withdrawal (SOPHCIG)
March 27, 2024 updated by: Centre Hospitalier Intercommunal Creteil
To evaluate the added value of Sophrology on the intensity of craving during cigarette withdrawal.
Study Overview
Status
Recruiting
Conditions
Intervention / Treatment
Detailed Description
Pilot study to evaluate the impact of sophrology on the intensity of craving and on certain determinants of cigarette consumption: number of cigarettes, anxiety, degree of dependence, motivation, confidence, fatigue, irritability, quality of sleep.
This pilot study could serve as a basis for the development of research on a larger cohort.
Study Type
Interventional
Enrollment (Estimated)
36
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Contact
- Name: Sylvie Ané
- Phone Number: +33 0145175035
- Email: sylvie.ane@chicreteil.fr
Study Contact Backup
- Name: Aude Sallard
- Phone Number: +33 0157023024
- Email: aude.sallard@chicreteil.fr
Study Locations
-
-
-
Créteil, France, 94000
- Recruiting
- CHI Créteil Equipe de liaison et de soins en addictologie (ELSA)
-
Contact:
- Sylvie Ané
- Phone Number: +33 0145175035
- Email: sylvie.ane@chicreteil.fr
-
Créteil, France, 94000
- Recruiting
- CHU Henri Mondor Service d'addictologie
-
Contact:
- Sandrine Lemeunier
- Email: sandrine.lemeunier@aphp.fr
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years to 75 years (Adult, Older Adult)
Accepts Healthy Volunteers
No
Description
Inclusion Criteria:
- First outpatient consultation in tobacco addiction department
- Consumption greater than or equal to 35 cigarettes per week
- Minimum age: 18 years old / Maximum age: 75 years old
- Absence of co-addiction of alcohol, other products and behavioural addictions (except if withdrawal for more than 1 year)
- Commitment by the patient not to practice hypnosis or mindfulness while participating in the study
- Mastering reading and writing skills
- Acceptance to participate in the protocol
- Affiliated to a social security system
Exclusion Criteria:
- Patient-reported psychosis
- Pregnant women
- Participation in other intervention research
- Patient under guardianship or curatorship
- Refusal to participate in the study
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Supportive Care
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: Sophrology
the patient must make 8 visits with interviews and questionnaires, including 7 visits with a session of sophrology
|
Patient must make 8 visits with interviews and questionnaires, including 7 visits with a session of sophrology.
|
No Intervention: Control
the patient must make 7 visits with interviews and questionnaires
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
FTCQ-12 questionnaire (French Tobacco Craving Questionnaire - 12 items) (0 to 84)
Time Frame: 6 months after the end of consultations
|
Comparison of the inte craving between the sophrology group and the control group at nsity of 6 months after the end of consultations, using the FTCQ-12 questionnaire.
|
6 months after the end of consultations
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Number of cigarettes smoked per day
Time Frame: 6 months after the end of consultations
|
Number of cigarettes smoked per day
|
6 months after the end of consultations
|
Motivation to Quit Smoking by Numerical Scale (0 to 5)
Time Frame: 6 months after the end of consultations
|
Assessment of Motivation to Quit Smoking
|
6 months after the end of consultations
|
Measuring Confidence in Withdrawal Success by numerical scale (0 to 5)
Time Frame: 6 months after the end of consultations
|
Measuring Confidence in Withdrawal Success
|
6 months after the end of consultations
|
Evaluation of sleep by numerical scale (0 to 5)
Time Frame: 6 months after the end of consultations
|
Evaluation of sleep quality
|
6 months after the end of consultations
|
Evaluation of irritability by numerical scale (0 to 5)
Time Frame: 6 months after the end of consultations
|
Evaluation of irritability levels
|
6 months after the end of consultations
|
Fatigue levels by numerical scale (0 to 5)
Time Frame: 6 months after the end of consultations
|
Evaluation of fatigue levels
|
6 months after the end of consultations
|
Fagerström test (0 to 11)
Time Frame: 6 months after the end of consultations
|
Comparison of dependency
|
6 months after the end of consultations
|
CO (carbon monoxide) test
Time Frame: 6 months after the end of consultations
|
Comparison of the evolution of the CO
|
6 months after the end of consultations
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Investigators
- Principal Investigator: Sylvie Ané, Centre Hospitalier Intercommunal Creteil
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
June 23, 2021
Primary Completion (Estimated)
December 23, 2024
Study Completion (Estimated)
December 23, 2025
Study Registration Dates
First Submitted
November 27, 2020
First Submitted That Met QC Criteria
January 6, 2021
First Posted (Actual)
January 7, 2021
Study Record Updates
Last Update Posted (Actual)
March 28, 2024
Last Update Submitted That Met QC Criteria
March 27, 2024
Last Verified
March 1, 2024
More Information
Terms related to this study
Keywords
Other Study ID Numbers
- SOPHCIG
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
NO
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Craving
-
City Rescue Mission Medical ClinicNot yet recruiting
-
Medical University of South CarolinaCompleted
-
University of PittsburghNational Center for Complementary and Integrative Health (NCCIH)Recruiting
-
University of Colorado, Colorado SpringsCompletedStress | Sleep | Craving | Well BeingUnited States
-
Centre Hospitalier St AnneDirection Générale de l'Offre de SoinsRecruiting
-
Brown UniversityCompletedStress Eating | Reward-based Eating | Craving-related EatingUnited States
-
Medical University of South CarolinaNational Institute on Alcohol Abuse and Alcoholism (NIAAA)CompletedAlcohol Drinking | CravingUnited States
-
National Institute of Mental Health (NIMH)RecruitingPain | Stress | Emotions | Craving | FrustrationUnited States
-
University of Colorado, BoulderNational Institute on Alcohol Abuse and Alcoholism (NIAAA); National Center...TerminatedAlcohol Craving | Mood ChangesUnited States
-
Medical University of South CarolinaVirginia Tech Carilion School of Medicine and Research InstituteTerminatedAddiction | Craving | Nicotine | Smoking, CigaretteUnited States
Clinical Trials on Sophrology
-
Assistance Publique Hopitaux De MarseilleUnknownFollicular Thyroid CancerFrance
-
University Hospital, MontpellierCompleted
-
Assistance Publique - Hôpitaux de ParisFondation de FranceCompleted
-
Institut Cancerologie de l'OuestRecruiting
-
Rennes University HospitalTerminatedParkinson Disease | Deep Brain StimulationFrance
-
University Hospital, Clermont-FerrandCentre National de la Recherche Scientifique, France; University Clermont Auvergne...RecruitingStress Related Disorder | Sophrology | Neurolinguistic ProgrammingFrance
-
University Hospital, MontpellierCompleted
-
Hopital FochCompleted
-
University Hospital, CaenCompletedPain | Hematologic Diseases | Diagnoses DiseaseFrance
-
Hospital Universitari Vall d'Hebron Research InstituteCompleted